# Temocillin Pharmacokinetics in Paediatrics

> **NCT02260102** · PHASE4 · UNKNOWN · sponsor: **Université Catholique de Louvain** · enrollment: 45 (estimated)

## Conditions studied

- Infection
- Liver Dysfunction
- Urinary Tract Infection

## Interventions

- **DRUG:** Temocillin

## Key facts

- **NCT ID:** NCT02260102
- **Lead sponsor:** Université Catholique de Louvain
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-02-17
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2022-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02260102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02260102, "Temocillin Pharmacokinetics in Paediatrics". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02260102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*